Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myeloma

Bone Marrow Transplant. 2020 Jun;55(6):1203-1205. doi: 10.1038/s41409-019-0674-2. Epub 2019 Sep 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Cell Maturation Antigen
  • Hematopoietic Stem Cells
  • Humans
  • Immunotherapy, Adoptive*
  • Male
  • Middle Aged
  • Multiple Myeloma* / therapy
  • Receptors, Chimeric Antigen*

Substances

  • B-Cell Maturation Antigen
  • Receptors, Chimeric Antigen